Takeaways from this week in optometry: May 5 - May 9
ARVO 2025: Rethinking centile growth curves in myopia management with Mark Bullimore, MCOptom, PhD
ARVO 2025: Perfuse Therapeutics announces positive results from phase 1/2a trial of PER-001, an intravitreal implant for glaucoma
Prevent Blindness voices support for reintroduction of EDVI Act